Sheila Gilbride-Wilson
Vice President, Clinical Operations & Data Management Orchard Therapeutics
Sheila Gilbride-Wilson is an experienced clinical operations leader with over three decades in the pharmaceutical and biotechnology industries. She has held senior positions at companies including Pfizer, Vertex Pharmaceuticals, ePharmaSolutions, Proteostasis Therapeutics, and Orchard Therapeutics. Most recently serving as Vice President of Clinical Operations and Data Management at Orchard Therapeutics, Sheila has led global teams in advancing clinical trials for ultra-rare disease gene therapies, bringing deep expertise in clinical operations, data management, compliance, and strategic leadership.
Seminars
Monday 23rd March 2026
Workshop B: Strategic Enterprise Decision-Making, Challenges & Execution for Gene Therapy Expanded Access Programs
11:45 am
- Defining the Strategic Role of Expanded Access Across the Asset Lifecycle
- Structured Decision Framework to Determine Whether and When to Launch EAPs
- Considerations in Execution of Expanded Access Programs
- End to End Expanded Access Program execution processes
